Aspiriant Capital Appreciation Fund has initiated a tender offer to purchase shares from its shareholders, amounting to approximately 5% of the fund's net assets, which is roughly $8,095,447. This strategic move is significant as it aims to enhance shareholder value and manage the fund's capital effectively.
The tender offer, filed under Schedule TO, allows shareholders to sell back their shares at their net asset value (NAV), calculated as of December 31, 2026. The offer will remain open until December 17, 2026, providing shareholders ample time to consider their options.
Background
Aspiriant Capital Appreciation Fund is a closed-end, non-diversified management investment company registered under the Investment Company Act of 1940. The fund is organized as a Delaware statutory trust and operates under the Central Index Key (CIK) 0001830974. It primarily focuses on capital appreciation through investments in a diversified portfolio.
Recent filings indicate the fund's active management strategy, including a previous tender offer on July 28, 2026, and consistent reporting of its net asset values. The fund's business address is c/o UMB Fund Services, Inc., located in Milwaukee, Wisconsin.
What the Filing Says
The recent filing states, "Aspiriant Capital Appreciation Fund is offering to purchase Shares in the Fund in an amount up to approximately 5.00% of the net assets of the Fund... from shareholders of the Fund at their net asset value." It also specifies that shareholders must tender their shares by 11:59 p.m. Eastern Time on December 17, 2026.
Impact
This tender offer may affect current shareholders looking to liquidate their investments, as it provides a structured opportunity to sell shares at a determined NAV. The move could also signal to potential investors that the fund is committed to maintaining a healthy balance sheet and shareholder engagement.
What's Next
The filing does not say what happens next, but shareholders will need to act by the specified deadline if they wish to participate in the tender offer. The fund may provide further updates or extensions as necessary.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










